Final Programme - iuphar

W23 Applying pharmacogenomics (PGX) from research
into clinical practice: Present and future
Tue 480 DPYD polymorphisms and adjuvant 5-FU/LV treatment outcome in colorectal cancer patients
Shoaib Afzal, (Denmark), SA Jensen, B Vainer, U Vogel, JB Sørensen, HE Poulsen
Tue 481 The study of CYP2C19 polymorphisms in Romanian epileptic patients
Anca Dana Buzoianu, (Romania), IC Bocsan, FC Militaru, R Popp, A Trifa, L Perju-Dumbrava
Tue 482 Genetic variation in the hTAS2R38 taste receptor and Brassica vegetables intake
Nela Gorovic, (Denmark), S Afzal, A Tjønneland, K Overvad, U Vogel, C Albrechtsen, HE Poulsen
Tue 483 CYP2D6 mRNA expression and genetic polymorphism in the small intestine of Japanese
Shinichi Kobayashi, (Japan), S Takenoshita-Nakaya, Y Kinoshita, N Matsumoto, Y Takeba, T Kumai
Tue 484 Impact of CYP2D6 and CYP3A5 gene polymorphisms on pharmacokinetics of oxycodone and its
demethylates and dose escalation rate in cancer patients
Takafumi Naito, (Japan), K Yamamoto, Y Takashina, M Tashiro, Y Kagawa, K Ohnishi, J Kawakami
Tue 485 Distribution and genotype frequency of the SNP 45T/G polymorphism in Iranian population: progression
to diabetes and response to pioglitazone
Fatemeh Namvaran, (Iran), P Rahimi-Moghaddam, N Azarpira
Tue 486 Renal secretion clearance of N1-methylnicotinamide as an endogenous biomarker for tubular organic
cation transporter type 2 activity in man
Ryuichi Ogawa, (Japan), Y Nobuoka, H Echizen
Tue 487 Role of ace and MTHFR genes polymorphisms in migraine
V Pizza, A Bisogno, E Lamaida, A Agresta, G Bandieramonte, A Volpe, R Galasso, L Galasso,
Anna Capasso, (Italy)
Tue 488 Polymorphism gene apolipoprotein E in migraine and cardiovascular disease
V Pizza, F Infante, G Schiavo, A Agresta, C Colucci d'Amato, A Bisogno, Anna Capasso, (Italy)
Tue 489 Interethnic and gender dependent differences in CYP2C19 activity. A comparison between Swedes and
Koreans
Margareta Ramsjö, (Sweden), E Aklillu, L Bohman, M Ingelman-Sundberg, H-K Roh, L Bertilsson
Tue 490 Impact of CYP2D6 genetics on serum concentration of escitalopram in relation to CYP2C19 genotype
Ida Rudberg, (Norway), M Hermann, H Refsum, E Molden
Tue 491 Impact of CYP3A5 and ABCB1 gene polymorphisms on plasma disposition of fentanyl and its clinical
responses in cancer patients with opioid switching to fentanyl transdermal system
Yoshiaki Takashina, (Japan), T Naito, Y Mino, K Ohnishi, J Kawakami
Tue 492 VKORC1 and CYP2C9 genotyping using a rapid single nucleotide polymorphism (SNP) detection system
named smart amplification process (SmartAmp) method
Minoru Watanabe, (Japan), N Matsumoto, T Kumai, M Tanaka, Y Mitani, Y Hayashizaki, S Kobayashi
Tue 493 A multiplexed primer extension denaturing high performance liquid chromatography method for the
identification of 3 ABCC2 (MRP2) genetic polymorphisms
Ian Westley, (Australia), J Coller, M Ward, A Evans, R Morris, B Sallustio
Tue 494 Lack of drug-drug interaction between ketoconazole and brivanib
Daphne Williams, (USA), S Syed, D Lathers, G Kollia, A Gupta, J Pursley, Y-Q Xia, E Masson
244 Tuesday 20 July ■ 13:00 - 14:00 ■ Poster Area